Skin manifestations of COVID-19 in children : Part 3

© 2020 British Association of Dermatologists..

The current COVID-19 pandemic is caused by the SARS-CoV-2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage of those infected. As time has passed, other symptoms have been recognized. The initial reports of cutaneous manifestations were from Italian dermatologists, probably because Italy was the first European country to be heavily affected by the pandemic. The overall clinical presentation, course and outcome of SARS-CoV-2 infection in children differ from those in adults as do the cutaneous manifestations of childhood. In this review, we summarize the current knowledge on the cutaneous manifestations of COVID-19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe. In Part 1, we discuss one of the first and most widespread cutaneous manifestations of COVID-19, chilblain-like lesions, and in Part 2 we expanded to other manifestations, including erythema multiforme, urticaria and Kawasaki disease-like inflammatory multisystemic syndrome. In this part of the review, we discuss the histological findings of COVID-19 manifestations, and the testing and management of infected children for both COVID-19 and any other pre-existing conditions.

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Clinical and experimental dermatology - Vol. 46, No. 3 (2021), p. 462-472

Language:

English

Contributors:

Andina, D
Belloni-Fortina, A
Bodemer, C
Bonifazi, E
Chiriac, A
Colmenero, I
Diociaiuti, A
El-Hachem, M
Fertitta, L
van Gysel, D
Hernández-Martín, A
Hubiche, T
Luca, C
Martos-Cabrera, L
Maruani, A
Mazzotta, F
Akkaya, A D
Casals, M
Ferrando, J
Grimalt, R
Grozdev, I
Kinsler, V
Morren, M A
Munisami, M
Nanda, A
Novoa, M P
Ott, H
Pasmans, S
Salavastru, C
Zawar, V
Torrelo, A
ESPD Group for the Skin Manifestations of COVID-19

Links:

Volltext

Keywords:

420K487FSG
Adolescent
Antibodies, Monoclonal, Humanized
COVID-19
COVID-19 Testing
Child
Dermatologic Agents
Dupilumab
Exanthema
Humans
Journal Article
Nicolau Syndrome
Pityriasis Rosea
Purpura
Review
SARS-CoV-2
Skin Diseases, Viral
Urticaria

Notes:

Date Completed 05.04.2021

Date Revised 05.04.2021

published: Print-Electronic

Citation Status MEDLINE

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1111/ced.14483

PMID:

33207021

PPN (Catalogue-ID):

NLM318734567